Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves’ disease and Graves’ ophthalmopathy
Open Access
- 30 November 2012
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 13 (1) , 116
Abstract
Background: Graves disease (GD) is an organ-specific autoimmune disease characterized by hyperthyroidism, diffuse goiter, autoantibodies against thyroid-specific antigens, and dermopathy. Studies of GD have demonstrated the importance of the Th2 and Th17 immune responses in mediating disease progression. In the present study, we investigated the role of a Th2 cytokine, thymic stromal lymphopoietin (TSLP), in GD and Th17 differentiation. Methods: In this study, we genotyped 470 patients with GD at 3 single nucleotide polymorphisms (SNPs) in TSLP. In addition, the serum concentrations of TSLP were determined in 432 patients and 272 controls. Ten patients and controls each were further screened using in vitro Th17 differentiation assays. The SNPs were genotyped using ABI TaqMan® SNP genotyping assays. For the Th17 differentiation assays, peripheral blood mononuclear cells (PBMCs) isolated from the patients and controls were placed into Th17 differentiation media, and interleukin 17 expression levels were determined. Results: Haplotype analysis indicated that patients with the Ht3 (TCC) haplotype have a 3.28-fold higher risk of developing GD (p = 0.007), whereas those with the Ht5 (TCG) haplotype had a 0.03-fold, reduced risk of developing GD (p = 1 × 10−14). SNP rs3806933 (p = 0.007) was associated with female Graves ophthalmopathy (GO). TSLP expression levels were higher in GD patients than in control subjects, and TLSP was also shown to promote the differentiation of Th17 cells in GD patients. Conclusions: These results suggest that polymorphisms in TSLP may be used as genetic markers for the diagnosis and prognosis of GD. Furthermore, TLSP may be a target for treating GD.Keywords
This publication has 21 references indexed in Scilit:
- Thymic Stromal Lymphopoietin Gene Promoter Polymorphisms Are Associated with Susceptibility to Bronchial AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Crohn disease: a current perspective on genetics, autophagy and immunity.2011
- Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritisArthritis & Rheumatism, 2011
- Association of functional polymorphisms in promoter regions ofIL5, IL6andIL13genes with development and prognosis of autoimmune thyroid diseasesClinical and Experimental Immunology, 2011
- The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritisRheumatology International, 2011
- Association of Interleukin-1β (IL1B) Polymorphisms with Graves' Ophthalmopathy in Taiwan Chinese PatientsInvestigative Ophthalmology & Visual Science, 2010
- Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin‐17A productionArthritis & Rheumatism, 2010
- Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2‐polarizing conditionsClinical & Experimental Allergy, 2009
- From interleukin‐23 to T‐helper 17 cells: human T‐helper cell differentiation revisitedImmunological Reviews, 2008
- Interleukin (IL)-23 Receptor Is a Major Susceptibility Gene for Graves’ Ophthalmopathy: The IL-23/T-helper 17 Axis Extends to Thyroid AutoimmunityThe Journal of Clinical Endocrinology & Metabolism, 2008